BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38234771)

  • 1. Precise single-cell transcriptomic mapping of normal and leukemic cell states reveals unconventional lineage priming in acute myeloid leukemia.
    Zeng AGX; Iacobucci I; Shah S; Mitchell A; Wong G; Bansal S; Gao Q; Kim H; Kennedy JA; Minden MD; Haferlach T; Mullighan CG; Dick JE
    bioRxiv; 2023 Dec; ():. PubMed ID: 38234771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
    Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M
    Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).
    Maag AH; Swanton H; Kull M; Vegi NM; Feuring M
    Cytometry A; 2023 Jul; 103(7):551-562. PubMed ID: 36647792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD71 in acute leukemia- An immunophenotypic marker for erythroid lineage or proliferation?
    Acharya S; Kala PS
    Indian J Pathol Microbiol; 2019; 62(3):418-422. PubMed ID: 31361230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.
    Mehtonen J; Teppo S; Lahnalampi M; Kokko A; Kaukonen R; Oksa L; Bouvy-Liivrand M; Malyukova A; Mäkinen A; Laukkanen S; Mäkinen PI; Rounioja S; Ruusuvuori P; Sangfelt O; Lund R; Lönnberg T; Lohi O; Heinäniemi M
    Genome Med; 2020 Nov; 12(1):99. PubMed ID: 33218352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.
    Kirtek T; Chen W; Laczko D; Bagg A; Koduru P; Foucar K; Venable E; Nichols M; Rogers HJ; Tam W; Orazi A; Hsi ED; Hasserjian RP; Wang SA; Arber DA; Weinberg OK
    Leuk Res; 2023 Jul; 130():107309. PubMed ID: 37210875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
    Takahashi K; Wang F; Morita K; Yan Y; Hu P; Zhao P; Zhar AA; Wu CJ; Gumbs C; Little L; Tippen S; Thornton R; Coyle M; Mendoza M; Thompson E; Zhang J; DiNardo CD; Jain N; Ravandi F; Cortes JE; Garcia-Manero G; Kornblau S; Andreeff M; Jabbour E; Bueso-Ramos C; Takaori-Kondo A; Konopleva M; Patel K; Kantarjian H; Futreal PA
    Nat Commun; 2018 Jul; 9(1):2670. PubMed ID: 29991687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
    Naghashpour M; Lancet J; Moscinski L; Zhang L
    Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL
    Weinberg OK; Dennis J; Zia H; Chen P; Chu A; Koduru P; Luu HS; Fuda F; Chen W
    Int J Lab Hematol; 2023 Apr; 45(2):170-178. PubMed ID: 36325594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoresistance in acute myeloid leukemia: An alternative single-cell RNA sequencing approach.
    Cheng PL; Hsiao TH; Chen CH; Hung MN; Jhan PP; Lee LW; Wu TS; Tsai JR; Teng CJ
    Hematol Oncol; 2023 Aug; 41(3):499-509. PubMed ID: 36790759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With
    Takeda R; Yokoyama K; Fukuyama T; Kawamata T; Ito M; Yusa N; Kasajima R; Shimizu E; Ohno N; Uchimaru K; Yamaguchi R; Imoto S; Miyano S; Tojo A
    Front Oncol; 2022; 12():799982. PubMed ID: 35402256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity.
    Galera P; Dilip D; Derkach A; Chan A; Zhang Y; Persuad S; Mishera T; Liu Y; Famulare C; Gao Q; Mata DA; Arcila M; Geyer MB; Stein E; Dogan A; Levine RL; Roshal M; Glass J; Xiao W
    medRxiv; 2023 Nov; ():. PubMed ID: 37961275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3).
    Jia Y; Lin D; Wang Z; Li C; Wang H; Wang J; Mi Y
    Diagn Pathol; 2022 Oct; 17(1):74. PubMed ID: 36199105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
    Fagnan A; Bagger FO; Piqué-Borràs MR; Ignacimouttou C; Caulier A; Lopez CK; Robert E; Uzan B; Gelsi-Boyer V; Aid Z; Thirant C; Moll U; Tauchmann S; Kurtovic-Kozaric A; Maciejewski J; Dierks C; Spinelli O; Salmoiraghi S; Pabst T; Shimoda K; Deleuze V; Lapillonne H; Sweeney C; De Mas V; Leite B; Kadri Z; Malinge S; de Botton S; Micol JB; Kile B; Carmichael CL; Iacobucci I; Mullighan CG; Carroll M; Valent P; Bernard OA; Delabesse E; Vyas P; Birnbaum D; Anguita E; Garçon L; Soler E; Schwaller J; Mercher T
    Blood; 2020 Aug; 136(6):698-714. PubMed ID: 32350520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).
    Khan M; Siddiqi R; Naqvi K
    Ann Hematol; 2018 Jun; 97(6):945-953. PubMed ID: 29546454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemia.
    Agarwal A; Bolosky WJ; Wilson DB; Eide CA; Olson SB; Fan G; Druker BJ
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24593-24599. PubMed ID: 31754026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
    Mejstrikova E; Volejnikova J; Fronkova E; Zdrahalova K; Kalina T; Sterba J; Jabali Y; Mihal V; Blazek B; Cerna Z; Prochazkova D; Hak J; Zemanova Z; Jarosova M; Oltova A; Sedlacek P; Schwarz J; Zuna J; Trka J; Stary J; Hrusak O
    Haematologica; 2010 Jun; 95(6):928-35. PubMed ID: 20145275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.
    Wang J; Farkas C; Benyoucef A; Carmichael C; Haigh K; Wong N; Huylebroeck D; Stemmler MP; Brabletz S; Brabletz T; Nefzger CM; Goossens S; Berx G; Polo JM; Haigh JJ
    PLoS Biol; 2021 Sep; 19(9):e3001394. PubMed ID: 34550965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.